vs

Side-by-side financial comparison of Invivyd, Inc. (IVVD) and LCNB CORP (LCNB). Click either name above to swap in a different company.

LCNB CORP is the larger business by last-quarter revenue ($23.9M vs $17.2M, roughly 1.4× Invivyd, Inc.). LCNB CORP runs the higher net margin — 23.7% vs -64.3%, a 88.0% gap on every dollar of revenue. On growth, Invivyd, Inc. posted the faster year-over-year revenue change (24.5% vs 5.1%).

Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.

LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.

IVVD vs LCNB — Head-to-Head

Bigger by revenue
LCNB
LCNB
1.4× larger
LCNB
$23.9M
$17.2M
IVVD
Growing faster (revenue YoY)
IVVD
IVVD
+19.4% gap
IVVD
24.5%
5.1%
LCNB
Higher net margin
LCNB
LCNB
88.0% more per $
LCNB
23.7%
-64.3%
IVVD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IVVD
IVVD
LCNB
LCNB
Revenue
$17.2M
$23.9M
Net Profit
$-11.1M
$5.7M
Gross Margin
Operating Margin
-73.0%
29.2%
Net Margin
-64.3%
23.7%
Revenue YoY
24.5%
5.1%
Net Profit YoY
40.0%
-7.6%
EPS (diluted)
$0.02
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVVD
IVVD
LCNB
LCNB
Q4 25
$17.2M
$23.9M
Q3 25
$13.1M
$23.8M
Q2 25
$11.8M
$22.8M
Q1 25
$11.3M
$21.5M
Q4 24
$13.8M
$22.7M
Q3 24
$9.3M
$21.4M
Q2 24
$2.3M
$19.3M
Q1 24
$0
$17.8M
Net Profit
IVVD
IVVD
LCNB
LCNB
Q4 25
$-11.1M
$5.7M
Q3 25
$-10.5M
$6.9M
Q2 25
$-14.7M
$5.9M
Q1 25
$-16.3M
$4.6M
Q4 24
$-18.4M
$6.1M
Q3 24
$-60.7M
$4.5M
Q2 24
$-47.2M
$925.0K
Q1 24
$-43.5M
$1.9M
Operating Margin
IVVD
IVVD
LCNB
LCNB
Q4 25
-73.0%
29.2%
Q3 25
-84.0%
35.6%
Q2 25
-127.8%
31.6%
Q1 25
-149.7%
25.6%
Q4 24
-139.1%
32.9%
Q3 24
-670.0%
24.9%
Q2 24
-2175.2%
4.9%
Q1 24
12.5%
Net Margin
IVVD
IVVD
LCNB
LCNB
Q4 25
-64.3%
23.7%
Q3 25
-79.7%
29.1%
Q2 25
-124.4%
26.0%
Q1 25
-144.1%
21.4%
Q4 24
-133.5%
27.0%
Q3 24
-653.1%
21.2%
Q2 24
-2086.9%
4.8%
Q1 24
10.7%
EPS (diluted)
IVVD
IVVD
LCNB
LCNB
Q4 25
$0.02
$0.40
Q3 25
$-0.06
$0.49
Q2 25
$-0.12
$0.41
Q1 25
$-0.14
$0.33
Q4 24
$-0.14
$0.44
Q3 24
$-0.51
$0.31
Q2 24
$-0.40
$0.07
Q1 24
$-0.38
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVVD
IVVD
LCNB
LCNB
Cash + ST InvestmentsLiquidity on hand
$226.7M
$21.6M
Total DebtLower is stronger
$104.4M
Stockholders' EquityBook value
$241.5M
$273.9M
Total Assets
$276.9M
$2.2B
Debt / EquityLower = less leverage
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVVD
IVVD
LCNB
LCNB
Q4 25
$226.7M
$21.6M
Q3 25
$85.0M
$35.9M
Q2 25
$34.9M
$49.8M
Q1 25
$48.1M
$37.7M
Q4 24
$69.3M
$35.7M
Q3 24
$106.9M
$39.4M
Q2 24
$147.9M
$34.9M
Q1 24
$189.4M
$33.0M
Total Debt
IVVD
IVVD
LCNB
LCNB
Q4 25
$104.4M
Q3 25
$104.7M
Q2 25
$105.0M
Q1 25
$104.6M
Q4 24
$155.2M
Q3 24
$155.7M
Q2 24
$162.2M
Q1 24
$162.6M
Stockholders' Equity
IVVD
IVVD
LCNB
LCNB
Q4 25
$241.5M
$273.9M
Q3 25
$93.1M
$269.9M
Q2 25
$42.8M
$263.5M
Q1 25
$54.1M
$258.7M
Q4 24
$67.5M
$253.0M
Q3 24
$83.2M
$253.2M
Q2 24
$140.6M
$245.2M
Q1 24
$178.5M
$233.7M
Total Assets
IVVD
IVVD
LCNB
LCNB
Q4 25
$276.9M
$2.2B
Q3 25
$139.2M
$2.2B
Q2 25
$89.1M
$2.3B
Q1 25
$103.7M
$2.3B
Q4 24
$129.5M
$2.3B
Q3 24
$161.9M
$2.3B
Q2 24
$177.3M
$2.4B
Q1 24
$215.5M
$2.3B
Debt / Equity
IVVD
IVVD
LCNB
LCNB
Q4 25
0.38×
Q3 25
0.39×
Q2 25
0.40×
Q1 25
0.40×
Q4 24
0.61×
Q3 24
0.61×
Q2 24
0.66×
Q1 24
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVVD
IVVD
LCNB
LCNB
Operating Cash FlowLast quarter
$-15.5M
$34.4M
Free Cash FlowOCF − Capex
$33.4M
FCF MarginFCF / Revenue
140.2%
Capex IntensityCapex / Revenue
0.0%
4.0%
Cash ConversionOCF / Net Profit
6.08×
TTM Free Cash FlowTrailing 4 quarters
$54.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVVD
IVVD
LCNB
LCNB
Q4 25
$-15.5M
$34.4M
Q3 25
$-8.3M
$14.0M
Q2 25
$-13.3M
$5.5M
Q1 25
$-21.1M
$2.2M
Q4 24
$-37.6M
$93.2M
Q3 24
$-41.1M
$11.9M
Q2 24
$-41.6M
$54.9M
Q1 24
$-50.2M
$-11.9M
Free Cash Flow
IVVD
IVVD
LCNB
LCNB
Q4 25
$33.4M
Q3 25
$13.7M
Q2 25
$-13.3M
$5.2M
Q1 25
$-21.3M
$2.1M
Q4 24
$-37.6M
$89.4M
Q3 24
$-41.1M
$10.5M
Q2 24
$53.8M
Q1 24
$-50.4M
$-12.8M
FCF Margin
IVVD
IVVD
LCNB
LCNB
Q4 25
140.2%
Q3 25
57.4%
Q2 25
-112.9%
23.0%
Q1 25
-188.2%
10.0%
Q4 24
-272.2%
394.0%
Q3 24
-441.6%
49.0%
Q2 24
278.6%
Q1 24
-71.8%
Capex Intensity
IVVD
IVVD
LCNB
LCNB
Q4 25
0.0%
4.0%
Q3 25
0.0%
1.3%
Q2 25
0.1%
1.0%
Q1 25
1.3%
0.3%
Q4 24
0.0%
16.7%
Q3 24
0.1%
6.7%
Q2 24
0.0%
5.9%
Q1 24
4.8%
Cash Conversion
IVVD
IVVD
LCNB
LCNB
Q4 25
6.08×
Q3 25
2.02×
Q2 25
0.92×
Q1 25
0.48×
Q4 24
15.23×
Q3 24
2.63×
Q2 24
59.35×
Q1 24
-6.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons